• Two marine molecules show potential to treat Alzheimer's disease

    1 month ago - By News Medical

    An interdisciplinary research study of the University of Barcelona identified two potential candidates to treat Alzheimer's disease. These are two marine molecules, meridianine and lignarenone B, able to alter the activity of GSK3B activity, a protein associated with several neurodegenerative diseases.
    Read more ...

     

  • Mixed Results for Aducanumab in Two Phase 3 AD Trials

    1 month ago - By Medscape

    A human monoclonal antibody in development significantly reduced clinical decline in people with early Alzheimer's disease in one randomized, placebo-controlled phase 3 study but not in an identical study.
    Medscape Medical News
    Read more ...

     

  • Clinical study shows promising results for treatment of VHL disease-associated renal tumors

    1 month ago - By News Medical

    In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor -2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease -associated renal cell carcinoma.
    Read more ...